Bill & Melinda Gates Foundation
Non-Profit
Active
New York, United States
300
17M
234
11.11
120
0.22
47
- Stages of investment
- Areas of investment
Summary
In 1997 was created Bill & Melinda Gates Foundation, which is appeared as VC. The company was established in North America in United States. The main department of described VC is located in the Seattle.
This organization was formed by Melinda Gates, William Gates. We also calculated 19 valuable employees in our database.
When the investment is from Bill & Melinda Gates Foundation the average startup value is more than 1 billion dollars. The fund is generally included in 7-12 deals every year. The top activity for fund was in 2017. Comparing to the other companies, this Bill & Melinda Gates Foundation performs on 14 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. Considering the real fund results, this VC is 28 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Biotechnology, Education. Among the various public portfolio startups of the fund, we may underline Moderna Therapeutics, Intarcia Therapeutics, Vir Biotechnology For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Bill & Melinda Gates Foundation, startups are often financed by Lux Capital, Flagship Pioneering, National Institutes of Health. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, ARCH Venture Partners, Flagship Pioneering. In the next rounds fund is usually obtained by Polaris Partners, ARCH Venture Partners, Flagship Pioneering.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 300
- Lead investments
- 120
- Exits
- 47
- Rounds per year
- 11.11
- Follow on index
- 0.22
- Investments by industry
- Biotechnology (149)
- Health Care (103)
- Pharmaceutical (58)
- Medical (50)
- Biopharma (35) Show 182 more
- Investments by region
-
- United States (156)
- Netherlands (6)
- United Kingdom (26)
- Germany (11)
- Belgium (5) Show 30 more
- Peak activity year
- 2023
- Number of Unicorns
- 12
- Number of Decacorns
- 14
- Number of Minotaurs
- 10
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 21
- Avg. valuation at time of investment
- 571M
- Group Appearance index
- 0.24
- Avg. company exit year
- 32
- Avg. multiplicator
- 0.34
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Pula Advisors | 17 Apr 2018 | Agriculture | Seed | 1M | Switzerland, Glarus, Glarus Nord |
| Pula Advisors | 15 Apr 2024 | Agriculture | Early Stage Venture | 20M | Switzerland, Glarus, Glarus Nord |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.